All Stories

  1. Recent Insights into the Role of PPARs in Disease
  2. Molecular Mechanisms of Cardiac Development and Disease
  3. Cardiomyocyte-Specific Wt1 Is Involved in Cardiac Metabolism and Response to Damage
  4. The Senescence Marker p16Ink4a—A Player of Liver Endothelial Cells Physiology
  5. Controversies and Recent Advances in Senescence and Aging
  6. Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease
  7. Editorial (Preface) “Cells/Cells of the Cardiovascular System—Editorial Highlights 2020–2021: The Book Selection”
  8. P16INK4A—More Than a Senescence Marker
  9. Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
  10. The Editor’s Choice Articles—Section “Cells of the Cardiovascular System” 2020–2021
  11. The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
  12. Transcriptional Regulation of Cardiac Development and Disease
  13. Dynamic Spatiotemporal Expression Pattern of the Senescence-Associated Factor p16Ink4a in Development and Aging
  14. Retinoic acid signaling is directly activated in cardiomyocytes and protects mouse hearts from apoptosis after myocardial infarction
  15. Every Beat You Take—The Wilms′ Tumor Suppressor WT1 and the Heart
  16. Implications of the Wilms’ Tumor Suppressor Wt1 in Cardiomyocyte Differentiation
  17. Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments
  18. PPARs and Myocardial Infarction
  19. Direct activation of RA signaling in cardiomyocytes protects hearts from apoptosis after myocardial infarction in mice
  20. WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1
  21. The Role of PPARs in Disease
  22. The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis
  23. PPARs and Angiogenesis—Implications in Pathology
  24. Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan
  25. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A
  26. PPAR Beta/Delta and the Hallmarks of Cancer
  27. Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression
  28. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1
  29. Erratum to “Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy”
  30. Myocardial-specific R-spondin3 drives proliferation of the coronary stems primarily through the Leucine Rich Repeat G Protein coupled receptor LGR4
  31. Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
  32. Andersen’s syndrome mutants produce a knockdown of inwardly rectifying K+ channel in mouse skeletal muscle in vivo
  33. Coronary Artery Formation Is Driven by Localized Expression of R-spondin3
  34. CDK9 Regulates Apoptosis of Myoblast Cells by Modulation of microRNA-1 Expression
  35. The differential spatiotemporal expression pattern of shelterin genes throughout lifespan
  36. Small RNA-directed epigenetic programming of embryonic stem cell cardiac differentiation
  37. Dnmt2 in Cardiac Growth: RNA Polymerase II and tRNA Methylation
  38. RNA Activation of the Vascular Endothelial Growth Factor Gene ( VEGF ) Promoter by Double-Stranded RNA and Hypoxia: Role of Noncoding VEGF Promoter Transcripts
  39. Extracardiac septum transversum/proepicardial endothelial cells pattern embryonic coronary arterio–venous connections
  40. Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy
  41. TRF2 acts as a transcriptional regulator in tumor angiogenesis
  42. The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression
  43. The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter
  44. Mouse Knockout of the Cholesterogenic Cytochrome P450 Lanosterol 14α-Demethylase (Cyp51) Resembles Antley-Bixler Syndrome
  45. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation
  46. The podocyte protein nephrin is required for cardiac vessel formation
  47. Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions
  48. The miR-124-Sox9 paramutation: RNA-mediated epigenetic control of embryonic and adult growth
  49. Peroxisome proliferator-activated receptor β stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin
  50. Role of the Wilms’ tumour transcription factor, Wt1, in blood vessel formation
  51. A novel Wilms’ tumor 1 gene mutation in a child with severe renal dysfunction and persistent renal blastema
  52. RNA Induction and Inheritance of Epigenetic Cardiac Hypertrophy in the Mouse
  53. The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo
  54. The Wilms’ tumor suppressor WT1 is associated with melanoma proliferation
  55. Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1
  56. The Wilms Tumor Suppressor Wt1 Promotes Cell Adhesion through Transcriptional Activation of the α4integrinGene
  57. An Inducible Mouse Model for PAX2-Dependent Glomerular Disease: Insights into a Complex Pathogenesis
  58. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1
  59. A splice variant of the Wilms' tumour suppressorWt1is required for normal development of the olfactory system
  60. The Major Podocyte Protein Nephrin Is Transcriptionally Activated by the Wilms’ Tumor Suppressor WT1
  61. 1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax
  62. The long-lasting impact of postnatal neuropeptide Y
  63. Characterization of stretch-activated ion currents in isolated atrial myocytes from human hearts
  64. Oxygen‐regulated expression of the Wilms’ tumor suppressorWt1involves hypoxia‐inducible factor‐1 (HIF‐1)
  65. Cardiac fibroblasts and the mechano-electric feedback mechanism in healthy and diseased hearts
  66. The complex life of WT1
  67. Mechanically induced potentials in atrial fibroblasts from rat hearts are sensitive to hypoxia/reoxygenation
  68. The Wilms’ tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b)
  69. Transgenic overexpression of the sarcoplasmic reticulum Ca 2+ ATPase improves reticular Ca 2+ handling in normal and diabetic rat hearts
  70. Decreased susceptibility of cardiac function to hypoxia-reoxygenation in renin-angiotensinogen transgenic rats
  71. The Wilms' tumor suppressorWt1is expressed in the coronary vasculature after myocardial infarction
  72. The Wilms' tumor geneWt1is required for normal development of the retina
  73. A possible role for atrial fibroblasts in postinfarction bradycardia
  74. Myocardial adrenergic dysfunction in rats with transgenic, human renin-dependent hypertension
  75. Mechanically induced potentials in rat atrial fibroblasts depend on actin and tubulin polymerisation
  76. Activation of Vitamin D Receptor by the Wilms' Tumor GeneProduct Mediates Apoptosis of Renal Cells
  77. Tie2 Receptor Expression Is Stimulated by Hypoxia and Proinflammatory Cytokines in Human Endothelial Cells
  78. Oxygen Radical System in Chronic Infarcted Rat Heart: The Effect of Combined Beta Blockade and ACE Inhibition
  79. Mechano-Electric Feedback in Right Atrium After Left Ventricular Infarction in Rats
  80. Mechanoelectric feedback after left ventricular infarction in rats
  81. Mechanically Induced Potentials in Fibroblasts from Human Right Atrium
  82. Mechanically induced potentials in fibroblasts from human right atrium
  83. Decreased Susceptibility of Contractile Function to Hypoxia/Reoxygenation in Chronic Infarcted Rat Hearts
  84. Electrophysiological Properties of Mechanosensitive Atrial Fibroblasts From Chronic Infarcted Rat Heart
  85. Contractile Function of Papillary Muscle From Rats With Different Infarct Size Afterβ-Adrenergic Blockade and ACE-inhibition
  86. Effects of hypoxia, simulated ischemia and reoxygenation on the contractile function of human atrial trabeculae